Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
CG1: Long-Acting Amylin Analogue Research Guide CG1 is a long-acting amylin analogue developed by the original developer, central to the clinical programme and co-formulated with semaglutide as CG1-Sema
Both medications are given as a once-weekly subcutaneous injection and share similar pharmacokinetic characteristics, such as absorption, distribution, metabolism, and excretion
Recombinant enzyme replacement therapy (ERT) using agalsidase- and agalsidase- clears cellular deposits of Gb3 and improves disease burden, respectively 11,12
While it may improve overall skin health and tone, it is not a direct scar removal treatment but can support gradual improvement
US$ 26.39
US$ 24.80
US$ 21.85
US$ 26.45
US$ 21.74
US$ 25.27
US$ 24.72
US$ 29.04
US$ 29.18
US$ 28.29
